NCT03279640

Brief Summary

Repetitive transcranial magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS) has been used for the modulation of stroke patients' motor function by altering the cortical excitability. Recently, more challenging approaches, such as stimulation of two or more sites or use of dual modality have been studied in stroke patients. In this study, simultaneous stimulation using both rTMS and tDCS (dual-mode stimulation) over bilateral primary motor cortices (M1s) was investigated to compare its modulatory effects with single rTMS stimulation in subacute stroke patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Mar 2014

Typical duration for not_applicable stroke

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 10, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 12, 2017

Completed
Last Updated

September 14, 2017

Status Verified

June 1, 2017

Enrollment Period

3 years

First QC Date

September 10, 2017

Last Update Submit

September 12, 2017

Conditions

Keywords

Motor NetworkResting-state fMRIRepetitive Transcranial Magnetic StimulationTranscranial Direct Current Stimulation

Outcome Measures

Primary Outcomes (1)

  • Neuroimaging Assessment

    Resting-state fMRI

    Change from baseline resting-state brain network at 8 weeks after intervention

Study Arms (2)

Dual-mode stimulation

EXPERIMENTAL

rTMS on ipsilesional M1 + tDCS on contralesional M1 10 Hz of rTMS was applied over the ipsilesional M1 for 20 minutes with simultaneous application of cathodal tDCS on the contralesional M1. Each participant's total FMA score is assessed and their resting-state fMRI data at two times: prior to stimulation (pre-stimulation) and 2 months after stimulation (post-stimulation) are acquired.

Device: rTMS on ipsilesional M1Device: tDCS on contralesional M1

Single stimulation

EXPERIMENTAL

rTMS on ipsilesional M1 10 Hz of rTMS over the ipsilesional M1 was applied for 20 minutes. Each participant's total FMA score is assessed and their resting-state fMRI data at two times: prior to stimulation (pre-stimulation) and 2 months after stimulation (post-stimulation) are acquired.

Device: rTMS on ipsilesional M1

Interventions

Dual-mode stimulationSingle stimulation
Dual-mode stimulation

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • First-ever stroke patients
  • Subacute stage (less than 4 weeks)
  • Total Fugl-Meyer Assessment (FMA) score under 84

You may not qualify if:

  • Major active neurological disease or psychiatric disease
  • A history of seizure
  • Metallic implants in their brain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Lee J, Park E, Lee A, Chang WH, Kim DS, Shin YI, Kim YH. Modulating Brain Connectivity by Simultaneous Dual-Mode Stimulation over Bilateral Primary Motor Cortices in Subacute Stroke Patients. Neural Plast. 2018 Feb 13;2018:1458061. doi: 10.1155/2018/1458061. eCollection 2018.

MeSH Terms

Conditions

StrokeMotor Disorders

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMental Disorders

Study Officials

  • Yun-Hee Kim, MD, PhD

    Samsung Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2017

First Posted

September 12, 2017

Study Start

March 1, 2014

Primary Completion

February 28, 2017

Study Completion

February 28, 2017

Last Updated

September 14, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share